Teacher Retirement System of Texas boosted its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 92.3% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 371,756 shares of the company's stock after buying an additional 178,386 shares during the quarter. Teacher Retirement System of Texas owned 0.43% of Pediatrix Medical Group worth $5,387,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds also recently added to or reduced their stakes in the stock. Nomura Asset Management Co. Ltd. increased its stake in Pediatrix Medical Group by 95.3% in the 4th quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company's stock valued at $33,000 after purchasing an additional 1,220 shares in the last quarter. GAMMA Investing LLC increased its position in shares of Pediatrix Medical Group by 219.5% in the first quarter. GAMMA Investing LLC now owns 2,569 shares of the company's stock valued at $37,000 after buying an additional 1,765 shares in the last quarter. AlphaQuest LLC raised its stake in shares of Pediatrix Medical Group by 65.9% during the 4th quarter. AlphaQuest LLC now owns 5,066 shares of the company's stock worth $66,000 after buying an additional 2,012 shares during the last quarter. Smartleaf Asset Management LLC boosted its position in shares of Pediatrix Medical Group by 750.9% in the 4th quarter. Smartleaf Asset Management LLC now owns 6,901 shares of the company's stock worth $91,000 after buying an additional 6,090 shares in the last quarter. Finally, Tower Research Capital LLC TRC grew its stake in Pediatrix Medical Group by 218.0% in the 4th quarter. Tower Research Capital LLC TRC now owns 7,445 shares of the company's stock valued at $98,000 after acquiring an additional 5,104 shares during the last quarter. 97.71% of the stock is owned by hedge funds and other institutional investors.
Pediatrix Medical Group Stock Performance
Shares of MD opened at $13.78 on Monday. Pediatrix Medical Group, Inc. has a 1 year low of $6.62 and a 1 year high of $17.67. The company's 50 day simple moving average is $13.89 and its 200 day simple moving average is $13.90. The company has a market capitalization of $1.18 billion, a price-to-earnings ratio of -13.64, a PEG ratio of 0.93 and a beta of 1.25. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.81 and a current ratio of 1.81.
Pediatrix Medical Group (NYSE:MD - Get Free Report) last issued its quarterly earnings results on Tuesday, May 6th. The company reported $0.33 earnings per share for the quarter, topping analysts' consensus estimates of $0.25 by $0.08. The company had revenue of $458.36 million for the quarter, compared to analyst estimates of $451.44 million. Pediatrix Medical Group had a positive return on equity of 17.43% and a negative net margin of 4.17%. The business's revenue for the quarter was down 7.4% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.20 EPS. On average, sell-side analysts predict that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.
Wall Street Analysts Forecast Growth
MD has been the subject of a number of research reports. Macquarie lifted their target price on shares of Pediatrix Medical Group from $19.00 to $20.00 and gave the stock an "outperform" rating in a research report on Thursday, May 8th. Truist Financial cut their price objective on Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating for the company in a research report on Friday, April 11th. Finally, UBS Group lowered their target price on Pediatrix Medical Group from $18.50 to $16.00 and set a "neutral" rating on the stock in a report on Monday, May 12th. Four research analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. According to MarketBeat.com, Pediatrix Medical Group presently has an average rating of "Hold" and an average price target of $16.67.
Check Out Our Latest Report on MD
About Pediatrix Medical Group
(
Free Report)
Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.
See Also
Want to see what other hedge funds are holding MD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Pediatrix Medical Group, Inc. (NYSE:MD - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Pediatrix Medical Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pediatrix Medical Group wasn't on the list.
While Pediatrix Medical Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
